• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
T-Cell Lymphomas Global Clinical Trials Review, H1, 2012 - Product Image

T-Cell Lymphomas Global Clinical Trials Review, H1, 2012

  • ID: 2051146
  • January 2012
  • Region: Global
  • 101 pages
  • GlobalData

T-Cell Lymphomas Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2012" provides data on the T-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating T-Cell Lymphomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific READ MORE >



List of Tables
List of Figures
Introduction
T-Cell Lymphomas
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of T-Cell Lymphomas
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in T-Cell Lymphomas Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Allos Therapeutics, Inc.
Clinical Trial Overview of Allos Therapeutics, Inc.
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Seattle Genetics, Inc.
Clinical Trial Overview of Seattle Genetics, Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
BioCryst Pharmaceuticals, Inc.
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc.
Clinical Trial Overview of Ligand Pharmaceuticals, Inc.
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
TSD Japan, Inc.
Clinical Trial Overview of TSD Japan, Inc.
Spectrum Pharmaceuticals, Inc.
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc.
Solasia Pharma K.K.
Clinical Trial Overview of Solasia Pharma K.K.
TopoTarget A/S
Clinical Trial Overview of TopoTarget A/S
Genmab A/S
Clinical Trial Overview of Genmab A/S
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Millennium Pharmaceuticals, Inc.
Clinical Trial Overview of Millennium Pharmaceuticals, Inc.
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Stanford University
Clinical Trial Overview of Stanford University
University of Nebraska
Clinical Trial Overview of University of Nebraska
Groupe d'Etudes de Lymphomes de L'Adulte
Clinical Trial Overview of Groupe d'Etudes de Lymphomes de L'Adulte
FUDAN University
Clinical Trial Overview of FUDAN University
Samsung Medical Center
Clinical Trial Overview of Samsung Medical Center
Zhengzhou University
Clinical Trial Overview of Zhengzhou University
NK-cell Tumor Study Group
Clinical Trial Overview of NK-cell Tumor Study Group
Alberta Health Services
Clinical Trial Overview of Alberta Health Services
The National Institute of Allergy and Infectious Diseases
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
Aarhus University
Clinical Trial Overview of Aarhus University
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Arizona Cancer Center
Clinical Trial Overview of Arizona Cancer Center
Wake Forest University
Clinical Trial Overview of Wake Forest University
Sun Yat-sen University
Clinical Trial Overview of Sun Yat-sen University
Albert Einstein College of Medicine of Yeshiva University
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University
Ontario Clinical Oncology Group
Clinical Trial Overview of Ontario Clinical Oncology Group
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone, 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries, 2012-
T-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries, 2012-
T-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase, 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
T-Cell Lymphomas Therapeutics Market, Global, Suspended Clinical Trials, 2012-
T-Cell Lymphomas Therapeutics Market, Global, Terminated Clinical Trials, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Allos Therapeutics, Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Ligand Pharmaceuticals, Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by TSD Japan, Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Solasia Pharma K.K., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by TopoTarget A/S, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Genmab A/S, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etudes de Lymphomes de L'Adulte, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhengzhou University, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by NK-cell Tumor Study Group, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Arizona Cancer Center, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Ontario Clinical Oncology Group, 2012-

List of Figures
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries (%), 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries (%), 2012-
T-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries (%), 2012-
T-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos